Adeno-Associated Virus– tag –
-
Orchestrating the Next Era of Decentralized and Automated Bioprocessing: 75% Efficiency Boost in AAV Manufacturing and QC Modernization
BioPharm International USA Overview BioPharm International discussed orchestrating the next era of the biopharmaceutical industry through decentralized manufacturing models, automated AAV manufacturing, and modernizing quality control (Q... -
Matica Biotechnology and Cirsium Biosciences Partner to Accelerate Flexible AAV Manufacturing via Matica Open Access Platform, Integrating Plant-Based Technology and Single-Use Innovations
BioSpace USA Overview Matica Biotechnology and Cirsium Biosciences announced the adoption of Matica's Open Access Platform to enhance flexibility, transparency, and scalability in Adeno-Associated Virus (AAV) development and manufacturin... -
Qihan Biotech Receives FDA RMAT and Breakthrough Therapy Designations for Universal Dual-Target CAR-T Therapy, Supported by PackGene Biotech’s CDMO Expertise
PackGene Biotech China Overview Qihan Biotech announced that its universal dual-target CAR-T therapy received both Regenerative Medicine Advanced Therapy (RMAT) and Breakthrough Therapy designations from the U.S. FDA. PackGene Biotech, a... -
Lipid Nanoparticles vs. Viral Vectors for Gene Delivery: A Comparative Analysis of Advantages and Applications
Pharma Almanac USA Overview This comparative analysis explores the distinct strengths of lipid nanoparticles (LNPs) and viral vectors in gene delivery. While viral vectors like AAV and lentivirus excel in high-efficiency, durable gene ex... -
Lonza Emphasizes End-to-End Process Scalability for High-Titer AAV Production Using HEK293 Media
Lonza Switzerland Overview Lonza underscores the critical importance of end-to-end process scalability for high-titer AAV production utilizing HEK293 media. The article highlights the pivotal role of benchtop stirred-tank bioreactors in ... -
Fujifilm Diosynth Biotechnologies Strengthens Technological Leadership in Cell Culture, Microbial Fermentation, Viral Vectors, and Cell Therapy Manufacturing
MabDesign France Overview Fujifilm Diosynth Biotechnologies is focused on combining its technological leadership with cGMP manufacturing facilities across key areas: cell culture, microbial fermentation, viral vectors, and cell therapy. ... -
Form Bio Launches FormManufacturing: An AI-Driven End-to-End Platform for Genetic Medicine Design and Manufacturing Optimization
Morningstar USA Overview Form Bio has introduced FormManufacturing™, an AI-driven, end-to-end platform for predicting, optimizing, and monitoring manufacturability of genetic medicines, debuting with an AAV-focused offering. Integrating ... -
Ajinomoto Develops Novel Culture Medium Supplement to Boost Gene Therapy Drug Productivity, Accelerating Biomanufacturing Efficiency
味の素株式会社 IRニュース Japan Overview Ajinomoto Group, in collaboration with its U.S. subsidiary Forge Biologics (acquired in 2023 for ~¥82.8 billion), has developed a novel culture medium supplement designed to significantly enhance ... -
Cytiva’s ELEVECTA Cell Line Receives FDA AMT Designation, Pioneering Next-Gen AAV Manufacturing with 99% Host Cell DNA Reduction
BioPharma BoardRoom USA Overview Cytiva, a Danaher company, has secured FDA Advanced Manufacturing Technology (AMT) designation for its ELEVECTA transient cell line, designed for adeno-associated virus (AAV) manufacturing. This pioneerin... -
CDMO Sector Sees Strategic Expansions: Andelyn Biosciences Launches LVV Platform, Made Scientific Partners with RoosterBio
DCAT Value Chain Insights USA Overview The biopharmaceutical contract development and manufacturing (CDMO) sector is experiencing significant strategic advancements, with Andelyn Biosciences unveiling its 'LVV curator platform' for stand...
